196 related articles for article (PubMed ID: 22768805)
1. hTERT, MYC and TP53 deregulation in gastric preneoplastic lesions.
Silva TC; Leal MF; Calcagno DQ; de Souza CR; Khayat AS; dos Santos NP; Montenegro RC; Rabenhorst SH; Nascimento MQ; Assumpção PP; de Arruda Cardoso Smith M; Burbano RR
BMC Gastroenterol; 2012 Jul; 12():85. PubMed ID: 22768805
[TBL] [Abstract][Full Text] [Related]
2. hTERT and TP53 deregulation in intestinal-type gastric carcinogenesis in non-human primates.
Leal MF; Calcagno DQ; Khayat AS; Silva TC; Muniz JA; Assumpção PP; de Arruda Cardoso Smith M; Burbano RR
Clin Exp Med; 2013 Aug; 13(3):221-4. PubMed ID: 22707033
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation.
Lan J; Xiong YY; Lin YX; Wang BC; Gong LL; Xu HS; Guo GS
World J Gastroenterol; 2003 Jan; 9(1):54-8. PubMed ID: 12508351
[TBL] [Abstract][Full Text] [Related]
4. Expression of human telomerase catalytic subunit gene in cancerous and precancerous gastric conditions.
Suzuki K; Kashimura H; Ohkawa J; Itabashi M; Watanabe T; Sawahata T; Nakahara A; Muto H; Tanaka N
J Gastroenterol Hepatol; 2000 Jul; 15(7):744-51. PubMed ID: 10937679
[TBL] [Abstract][Full Text] [Related]
5. Coordinate increase of telomerase activity and c-Myc expression in Helicobacter pylori-associated gastric diseases.
Zhang GX; Gu YH; Zhao ZQ; Xu SF; Zhang HJ; Wang HD; Hao B
World J Gastroenterol; 2004 Jun; 10(12):1759-62. PubMed ID: 15188501
[TBL] [Abstract][Full Text] [Related]
6. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer.
Calcagno DQ; Freitas VM; Leal MF; de Souza CR; Demachki S; Montenegro R; Assumpção PP; Khayat AS; Smith Mde A; dos Santos AK; Burbano RR
BMC Gastroenterol; 2013 Sep; 13():141. PubMed ID: 24053468
[TBL] [Abstract][Full Text] [Related]
7. [Coordinated expression of c-Myc and telomerase activity in Helicobacter pylori infected gastric diseases].
Zhang GX; Zhao ZQ; Gu YH; Xu SF; Zhang HJ
Zhonghua Nei Ke Za Zhi; 2003 Sep; 42(9):618-20. PubMed ID: 14514388
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in proximal and distal gastric neoplastic and preneoplastic lesions using immunohistochemical detection of hTERT.
Gulmann C; Lantuejoul S; Grace A; Leader M; Patchett S; Kay E
Dig Liver Dis; 2005 Jun; 37(6):439-45. PubMed ID: 15893283
[TBL] [Abstract][Full Text] [Related]
9. Extensive alteration in the expression profiles of TGFB pathway signaling components and TP53 is observed along the gastric dysplasia-carcinoma sequence.
Kim SH; Lee SH; Choi YL; Wang LH; Park CK; Shin YK
Histol Histopathol; 2008 Dec; 23(12):1439-52. PubMed ID: 18830930
[TBL] [Abstract][Full Text] [Related]
10. Bax and Bcl-2 protein expression in gastric precancerous lesions: immunohistochemical study.
Anagnostopoulos GK; Stefanou D; Arkoumani E; Sakorafas G; Pavlakis G; Arvanitidis D; Tsianos E; Agnantis NJ
J Gastroenterol Hepatol; 2005 Nov; 20(11):1674-8. PubMed ID: 16246184
[TBL] [Abstract][Full Text] [Related]
11. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type.
Ranzani GN; Luinetti O; Padovan LS; Calistri D; Renault B; Burrel M; Amadori D; Fiocca R; Solcia E
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):223-31. PubMed ID: 7606196
[TBL] [Abstract][Full Text] [Related]
12. Analysis of p53 expression in precancerous and malignant gastric mucosa.
Romiti A; Moretti A; Vecchione A; Muraro R; Feudi ML; Rinaldi V; Mancini R; Valli C; Mozzicafreddo A; Frati L; Tomao S
Oncol Rep; 1998; 5(1):109-13. PubMed ID: 9458303
[TBL] [Abstract][Full Text] [Related]
13. [Point mutation of TP53 suppressor gene in pre-neoplastic and neoplastic lesions of the stomach].
Araya JC; Roa JC; Villaseca MA; Roa I; Guzmán P; Alvarado C; Melo A
Rev Med Chil; 2003 Apr; 131(4):359-65. PubMed ID: 12870229
[TBL] [Abstract][Full Text] [Related]
14. Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype.
Cassaro M; Rugge M; Tieppo C; Giacomelli L; Velo D; Nitti D; Farinati F
J Clin Pathol; 2007 Jun; 60(6):615-21. PubMed ID: 17557866
[TBL] [Abstract][Full Text] [Related]
15. [Genetic changes in chronic gastritis: study of microsatellite instability and loss of heterozygosity].
Roa JC; Villaseca MA; Roa I; Araya JC
Rev Med Chil; 2003 Dec; 131(12):1365-74. PubMed ID: 15022398
[TBL] [Abstract][Full Text] [Related]
16. p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia.
Ochiai A; Yamauchi Y; Hirohashi S
Int J Cancer; 1996 Feb; 69(1):28-33. PubMed ID: 8600055
[TBL] [Abstract][Full Text] [Related]
17. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer.
Ebert MP; Günther T; Hoffmann J; Yu J; Miehlke S; Schulz HU; Roessner A; Korc M; Malfertheiner P
Cancer Res; 2000 Apr; 60(7):1995-2001. PubMed ID: 10766190
[TBL] [Abstract][Full Text] [Related]
18. [Microsatellite instability and loss of heterozygosity in neoplastic and preneoplastic gastric lesions].
Roa JC; Araya JC; Villaseca MA; Roa I; Correa P
Rev Med Chil; 2003 Nov; 131(11):1227-36. PubMed ID: 14743682
[TBL] [Abstract][Full Text] [Related]
19. OCT-1 is over-expressed in intestinal metaplasia and intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric cells.
Almeida R; Almeida J; Shoshkes M; Mendes N; Mesquita P; Silva E; Van Seuningen I; Reis CA; Santos-Silva F; David L
J Pathol; 2005 Dec; 207(4):396-401. PubMed ID: 16278805
[TBL] [Abstract][Full Text] [Related]
20. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer.
Boussioutas A; Li H; Liu J; Waring P; Lade S; Holloway AJ; Taupin D; Gorringe K; Haviv I; Desmond PV; Bowtell DD
Cancer Res; 2003 May; 63(10):2569-77. PubMed ID: 12750281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
